Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Cash flows from operating activities:              
Net loss $ (19,193,000) $ (7,403,000) $ (4,550,000) $ (4,037,000) $ (33,377,000) $ (13,261,000)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation and amortization         1,467,000 1,032,000  
Loss from impairment on assets held for sale         9,680,000 0  
Write-off of prepaid services         3,196,000 0  
Write-off of intangible assets 481,000   0   481,000 0  
Loss on disposal of assets 0   0   85,000 0  
Stock-based compensation expense         1,884,000 1,519,000  
Non-cash lease expense         749,000 687,000  
Deferred income taxes         56,000 0  
Change in fair value of earnout liability 0   (1,784,000)   0 (1,784,000)  
Interest receivable on short-term investments         (611,000) 0  
Change in fair value of warrant liabilities 0   (31,000)   0 (1,558,000)  
Change in operating assets and liabilities:              
Accounts receivable         (2,226,000) 710,000  
Inventory         (662,000) (152,000)  
Prepaid expenses and other assets         (89,000) (1,335,000)  
Accounts payable         (425,000) (396,000)  
Accrued expenses and other liabilities         (1,794,000) 713,000  
Operating lease liabilities         (721,000) (732,000)  
Deferred revenue         866,000 (458,000)  
Net cash used in operating activities         (21,441,000) (15,015,000)  
Cash flows from investing activities:              
Purchases of property and equipment         (2,796,000) (9,043,000)  
Purchase of short-term investments         (9,769,000) 0  
Proceeds from settlement of short-term investments         20,000,000 0  
Cash paid for acquisitions, net of cash acquired         0 (8,861,000)  
Net cash provided by (used in) investing activities         7,435,000 (17,904,000)  
Cash flows from financing activities:              
Proceeds received from other finance obligations         993,000 0  
Principal payments on finance leases         (45,000) 0  
Payments on other finance obligations         (17,000) 0  
Payments of taxes on restricted stock units withheld for employee taxes         (169,000) 0  
Proceeds from issuance of common stock         118,000 289,000  
Net cash provided by financing activities         880,000 289,000  
Net change in cash and cash equivalents and restricted cash         (13,126,000) (32,630,000)  
Effect of change in foreign currency exchange rates on cash and cash equivalents and restricted cash         13,000 (112,000)  
Cash and cash equivalents and restricted cash at beginning of period   $ 30,769,000   $ 79,819,000 30,769,000 79,819,000 $ 79,819,000
Cash and cash equivalents and restricted cash at end of period $ 17,656,000   $ 47,077,000   17,656,000 47,077,000 $ 30,769,000
Supplemental disclosure of cash and non-cash transactions:              
Cash paid for interest         87,000 0  
Purchase of property and equipment included in accounts payable         39,000 0  
Issuance of common stock upon settlement of earnout consideration liability         $ 537,000 $ 0